Evidence for a differential opioidergic involvement in the analgesic effect of antidepressants: Prediction for efficacy in animal models of neuropathic pain?

British Journal of Pharmacology

Volumn 163, Issue 4, 2011, Pages 792-803

  Wattiez, A S ^a,b   Libert, F ^a,b   Privat, A M ^a,b   Loiodice, S ^a,b   Fialip, J ^a,b   Eschalier, A ^a,b   Courteix, C ^a,b  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b INSERM   (France)

Author keywords

hyperalgesia; neuropathic pain; opioidergic mechanism; SSNRI; tricyclic antidepressants

Indexed keywords

CLOMIPRAMINE; DULOXETINE; MILNACIPRAN; NALOXONE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; HYPERALGESIA; MALE; NERVE INJURY; NEUROPATHIC PAIN; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

ANALGESICS; ANIMALS; ANTIDEPRESSIVE AGENTS; CLOMIPRAMINE; CYCLOPROPANES; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; HYPERALGESIA; MALE; NALOXONE; NEURALGIA; RATS; RATS, SPRAGUE-DAWLEY; THIOPHENES;

EID: 79958056690     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01297.x     Document Type: Article

References (40)

1. Ardid D, Guilbaud G, (1992). Antinociceptive effects of acute and 'chronic' injections of tricyclic antidepressant drugs in a new model of mononeuropathy in rats. Pain 49: 279-287.
2. Bennett GJ, Xie YK, (1988). A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33: 87-107.
3. Bomholt SF, Mikkelsen JD, Blackburn-Munro G, (2005). Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain. Neuropharmacology 48: 252-263. (Pubitemid 40208261)
4. Botney M, Fields HL, (1983). Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system. Ann Neurol 13: 160-164. (Pubitemid 13188210)
5. Carter NJ, McCormack PL, (2009). Duloxetine: a review of its use in the treatment of generalized anxiety disorder. CNS Drugs 23: 523-541.
6. Coudore-Civiale MA, Courteix C, Boucher M, Meen M, Fialip J, Eschalier A, et al,. (2000). Potentiation of morphine and clomipramine analgesia by cholecystokinin -B antagonist CI-988 in diabetic rats. Neurosci Lett 286: 37-40. (Pubitemid 30259115)
7. Courteix C, Eschalier A, Lavarenne J, (1993). Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain. Pain 53: 81-88. (Pubitemid 23137271)
8. Courteix C, Bardin M, Chantelauze C, Lavarenne J, Eschalier A, (1994). Study of the sensitivity of the diabetes-induced pain model in rats to a range of analgesics. Pain 57: 153-160. (Pubitemid 24168732)
9. Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, et al,. (2007). Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 132: 237-251. (Pubitemid 350051570)
10. Eschalier A, (1990). [Analgesics of the morphine type (and their antagonists)]. Rev Prat 40: 1895-1901. (Pubitemid 20291931)
11. Eschalier A, Fialip J, Varoquaux O, Makambila MC, Marty H, Bastide P, (1988). Pharmacokinetic patterns of repeated administration of antidepressants in animals. I. Implications for antinociceptive action of clomipramine in mice. J Pharmacol Exp Ther 245: 963-968.
12. Eschalier A, Picard P, Dubray C, (2000). [Analgesics. Utilization principles and rules, posology of morphine and its derivatives]. Rev Prat 50: 907-915.
13. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH, (2005). Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 118: 289-305. (Pubitemid 41752987)
14. Forman LJ, Estilow S, Lewis M, Vasilenko P, (1986). Streptozocin diabetes alters immunoreactive beta-endorphin levels and pain perception after 8 wk in female rats. Diabetes 35: 1309-1313. (Pubitemid 17199161)
15. Gilron I, (2010). Clinical pharmacology of antidepressants and anticonvulsants for the management of pain. In:, Mogil JS, (ed.). Pain 2010: An Updated Review, Refresher Course Syllabus, IASP Press: Seattle, pp. 193-206.
16. Isenberg KE, Cicero TJ, (1984). Possible involvement of opiate receptors in the pharmacological profiles of antidepressant compounds. Eur J Pharmacol 103: 57-63. (Pubitemid 14031139)
17. Iyengar S, Webster AA, Hemrick-Luecke SK, Xu JY, Simmons RM, (2004). Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats. J Pharmacol Exp Ther 311: 576-584. (Pubitemid 39391542)
18. Kajdasz DK, Iyengar S, Desaiah D, Backonja MM, Farrar JT, Fishbain DA, et al,. (2007). Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies. Clin Ther 29 (Suppl.): 2536-2546. (Pubitemid 350299457)
19. King T, Rao S, Vanderah T, Chen Q, Vardanyan A, Porreca F, (2006). Differential blockade of nerve injury-induced shift in weight bearing and thermal and tactile hypersensitivity by milnacipran. J Pain 7: 513-520. (Pubitemid 43929433)
20. Kuraishi Y, Takasaki I, Nojima H, Shiraki K, Takahata H, (2004). Effects of the suppression of acute herpetic pain by gabapentin and amitriptyline on the incidence of delayed postherpetic pain in mice. Life Sci 74: 2619-2626. (Pubitemid 38369359)
21. Langohr HD, Stohr M, Petruch F, (1982). An open and double-blind cross-over study on the efficacy of clomipramine (Anafranil) in patients with painful mono- and polyneuropathies. Eur Neurol 21: 309-317. (Pubitemid 12038947)
22. Ling B, Authier N, Balayssac D, Eschalier A, Coudoré F, (2007). Behavioral and pharmacological description of oxaliplatin-induced neuropathy in rat. Pain 128: 225-234. (Pubitemid 46389544)
23. Marchand F, Alloui A, Chapuy E, Hernandez A, Pelissier T, Ardid D, et al,. (2003a). The antihyperalgesic effect of venlafaxine in diabetic rats does not involve the opioid system. Neurosci Lett 342: 105-108. (Pubitemid 36513920)
24. Marchand F, Ardid D, Chapuy E, Alloui A, Jourdan D, Eschalier A, (2003b). Evidence for an involvement of supraspinal delta- and spinal mu-opioid receptors in the antihyperalgesic effect of chronically administered clomipramine in mononeuropathic rats. J Pharmacol Exp Ther 307: 268-274. (Pubitemid 37151917)
25. Mico JA, Ardid D, Berrocoso E, Eschalier A, (2006). Antidepressants and pain. Trends Pharmacol Sci 27: 348-354. (Pubitemid 43963184)
26. Mochizuki D, Hokonohara T, Kawasaki K, Miki N, (2002a). Repeated administration of milnacipran induces rapid desensitization of somatodendritic 5-HT1A autoreceptors but not postsynaptic 5-HT1A receptors. J Psychopharmacol 16: 253-260. (Pubitemid 34983082)
27. Mochizuki D, Tsujita R, Yamada S, Kawasaki K, Otsuka Y, Hashimoto S, et al,. (2002b). Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats. Psychopharmacology 162: 323-332. (Pubitemid 34762292)
28. Neliat G, Bodinier MC, Panconi E, Briley M, (1996). Lack of effect of repeated administration of milnacipran, a double noradrenaline and serotonin reuptake inhibitor, on the beta-adrenoceptor-linked adenylate cyclase system in the rat cerebral cortex. Neuropharmacology 35: 589-593. (Pubitemid 26306774)
29. Obata H, Saito S, Koizuka S, Nishikawa K, Goto F, (2005). The monoamine-mediated antiallodynic effects of intrathecally administered milnacipran, a serotonin noradrenaline reuptake inhibitor, in a rat model of neuropathic pain. Anesth Analg 100: 1406-1410. Table of Contents. (Pubitemid 40577395)
30. Onal A, Parlar A, Ulker S, (2007). Milnacipran attenuates hyperalgesia and potentiates antihyperalgesic effect of tramadol in rats with mononeuropathic pain. Pharmacol Biochem Behav 88: 171-178. (Pubitemid 350116001)
31. Panerai AE, Sacerdote P, Brini A, Bianchi M, Mantegazza P, (1987). Autotomy and central nervous system neuropeptides after section of the sciatic nerve in rats of different strains. Pharmacol Biochem Behav 28: 385-388. (Pubitemid 18002790)
32. Przewlocki R, Przewlocka B, (2001). Opioids in chronic pain. Eur J Pharmacol 429: 79-91. (Pubitemid 33043984)
33. Randall LO, Selitto JJ, (1957). A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther 111: 409-419.
34. Sacerdote P, Brini A, Mantegazza P, Panerai AE, (1987). A role for serotonin and beta-endorphin in the analgesia induced by some tricyclic antidepressant drugs. Pharmacol Biochem Behav 26: 153-158. (Pubitemid 18005618)
35. Sindrup SH, Gram LF, Skjold T, Grodum E, Brosen K, Beck-Nielsen H, (1990). Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study. Br J Clin Pharmacol 30: 683-691. (Pubitemid 20377596)
36. Sindrup SH, Otto M, Finnerup NB, Jensen TS, (2005). Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol 96: 399-409. (Pubitemid 40835693)
37. Suzuki T, Ueta K, Tamagaki S, Mashimo T, (2008). Antiallodynic and antihyperalgesic effect of milnacipran in mice with spinal nerve ligation. Anesth Analg 106: 1309-1315. Table of Contents. (Pubitemid 351450565)
38. Takeda R, Watanabe Y, Ikeda T, Abe H, Ebihara K, Matsuo H, et al,. (2009). Analgesic effect of milnacipran is associated with c-Fos expression in the anterior cingulate cortex in the rat neuropathic pain model. Neurosci Res 64: 380-384.
39. Woolf CJ, Bennett GJ, Doherty M, Dubner R, Kidd B, Koltzenburg M, et al,. (1998). Towards a mechanism-based classification of pain? Pain 77: 227-229. (Pubitemid 28451510)
40. Zimmermann M, (1983). Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110. (Pubitemid 13058546)